This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Pt Dexa Medica. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Dina Rahmi: Innovator in Pharmaceutical Dosage Forms
Introduction
Dina Rahmi is a prominent inventor based in Tangerang, Indonesia. She has made significant contributions to the field of pharmaceuticals, particularly in developing innovative dosage forms that address critical health issues. Her work focuses on creating effective treatments that can inhibit tumor growth and alleviate inflammation.
Latest Patents
Dina holds 1 patent for a pharmaceutical dosage form comprising an extract that exhibits antineoplastic, anti-inflammatory, and antiangiogenic activity. This innovative formulation serves multiple purposes: as an antineoplastic agent, it inhibits tumor growth; as an anti-inflammatory agent, it relieves inflammation and pain; and as an antiangiogenic agent, it prevents cancer metastasis by inhibiting the growth of new blood vessels.
Career Highlights
Dina Rahmi is currently associated with Pt Dexa Medica, a leading pharmaceutical company in Indonesia. Her role involves research and development, where she applies her expertise to create effective pharmaceutical solutions. Her dedication to improving health outcomes through innovative treatments has positioned her as a key figure in her field.
Collaborations
Dina has collaborated with notable colleagues, including Raymond R Tjandrawinata and Asep Aripin. These partnerships have enhanced her research efforts and contributed to the advancement of pharmaceutical innovations.
Conclusion
Dina Rahmi's contributions to pharmaceutical science exemplify her commitment to innovation and improving health outcomes. Her work continues to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile